Pharmacological Treatment for Body Dysmorphic Disorder.
- Author:
Ki Chung PAIK
1
Author Information
1. Department of Psychiatry, Dankook University College of Medicine, Cheon-An, Korea. kcpaik@korent.net
- Publication Type:Review
- Keywords:
Body dysmorphic disorder;
Pharmacotherapy;
Obsessive-compulsive disorder
- MeSH:
Antipsychotic Agents;
Body Dysmorphic Disorders*;
Brain;
Buspirone;
Clomipramine;
Drug Therapy;
Obsessive-Compulsive Disorder
- From:Korean Journal of Psychopharmacology
2001;12(4):277-286
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
In spite of the long history of notice, research on the pharmacotherapy of body dysmorphic disorder is limited. No placebo-controlled, continuation, maintenance, or discontinuation studies have been published. But accumulated data and experiences in recent days enable us even roughly to set up a pharmacological treatment step for body dysmorphic disorder. In addition to the clinical aspect of body dysmorphic disorder and its relation to obsessive-compulsive disorder, this article reviewed recent researches and clinical experiences about the pharmacotheray issues like SRI treatment, augmented treatment strategy using buspirone or neuroleptics or others, clomipramine pulse-loaded intravenous therapy, and other treatment methods including ECT and brain surgery, mainly for the purpose of making helpful guidelines for the clinicians. Some tips about cognitive-behavior therapy and future research directions were also added.
